GLP-1RAs: glucagon-like peptide-1 receptor agonists, BCAA: branched chain amino acids, mTOR: mammalian target of rapamycin, DXA: dual-energy X-ray absorptiometry, BIA: bioimpedance analysis Novel pharmacological approaches Besides behavioral strategies, emerging pharmacologic agents, comprising anabolic and anti-catabolic drugs, have been demonstrated to be effective in the prevention and treatment of sarcopenia or disproportionate lean mass loss in patients receiving GLP-1RAs
Before considering any peptide therapy, its crucial to prioritize safety and consult with a medical professional
Most patients adapt within 24 weeks as their body adjusts to the medication
Animal experiments have revealed that the adrenal glands contain the highest concentration of L-carnitine, followed by the heart, bone, muscle, adipose tissue, and liver
Pregnancy and breastfeeding increase B12 requirements, and pregnant women with B12 deficiency may need more frequent monitoring and potentially adjusted treatment schedules
